Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. of $400 million aggregate principal amount of its 1.000%…
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Silicon Laboratories Inc. of $535 million aggregate principal amount of its…
Davis Polk advised the joint book-running managers and representatives of the initial purchasers in connection with a Rule 144A offering by 1Life Healthcare, Inc. of $275 million…
Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Five9, Inc. of an aggregate principal amount of …
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Under Armour, Inc. of $440 million aggregate principal amount of its 1.500%…
Davis Polk advised the representatives of the several underwriters in connection with a SEC-registered offering by RealPage, Inc. of $345 million aggregate principal amount of its 1.500%…
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Plug Power Inc. of $200 million aggregate principal amount of its 3.750%…
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Veeco Instruments Inc. of an aggregate principal amount of $125 million of…
Davis Polk the initial purchasers in connection with a Rule 144A offering by Cantel Medical Corp. of $140 million principal amount of 3.250% convertible senior notes due 2025. Cantel’s…
Davis Polk advised the remarketing agents on the remarketing of 750,000 shares of Stanley Black & Decker’s Series C cumulative perpetual convertible preferred stock, without par…